Profile of Patients Diagnosed with Developmental Dysplasia of the Hip

Renan de Oliveira Barbosa1, Elaine Pinto Albernaz1

  • 1Faculdade de Medicina, Universidade Católica de Pelotas, Pelotas, RS, Brasil.

Insights

Developmental dysplasia of the hip (DDH) screening is crucial for all newborns. Early diagnosis via physical exams and ultrasound prevents delayed treatment in infants.

Area of Science:

  • Pediatrics
  • Orthopedics
  • Public Health

Background:

  • Developmental dysplasia of the hip (DDH) is a condition requiring early detection and management.
  • Implementing a standardized protocol for DDH diagnosis and treatment is essential for improved patient outcomes.

Purpose of the Study:

  • To characterize the patient profile of developmental dysplasia of the hip (DDH).
  • To evaluate the effectiveness of a DDH treatment and follow-up protocol.
  • To identify risk factors associated with DDH diagnosis.

Main Methods:

  • A cross-sectional study was conducted in Pelotas, Southern Brazil, involving DDH patients born between January 2014 and December 2016.
  • Data collected included ethnicity, gender, birth weight, fetal presentation, affected hip, gestational age, maternal age, and family history.
  • Medical records were compared with data from the Brazilian National Information System on Live Births (SINASC).

Main Results:

  • Thirty-three DDH patients were identified, with a higher prevalence in females (four-fold increased probability, p < 0.001) and the left hip being most affected.
  • Newborns in breech presentation showed a significantly higher probability of DDH (15-fold increased probability, p < 0.001).
  • No significant associations were found with birth weight, gestational age, ethnicity, or maternal age.

Conclusions:

  • Screening for DDH in all newborns is essential.
  • Physical examinations for DDH must be complemented by ultrasound imaging to prevent delayed diagnosis.
  • Early detection and intervention are critical for managing DDH effectively.